These side effects were notably milder in comparison to an inhibitor of the two bromodomains. A detailed molecular analysis also revealed that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes.  ― Stephen Taylor 88 These preclinical studies provide paradigms for future clinical trials in AML, and the usage https://mitchb332oal5.blogtov.com/profile